1. 2178 Locoregional treatment for advanced biliary tract cancer (aBTC): Evaluation of efficacy and safety. (September 2015) Authors: Marsico, V.A.; Vasile, E.; Vivaldi, C.; Vaccaro, V.; Brandi, G.; Leone, F.; Milella, M.; Fornaro, L.; Aprile, G.; Rumano, L.V.; Santini, D.; Carcea, E.; Aliberti, C.; Lonardi, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2249 Comparison of Everolimus (EV) plus somatostatin analog (SSA) administered before or after chemotherapy (CT) or PRRT in advanced G1-G2 Neuroendocrine Tumor (NET) progressed after SSA: analysis of different sequences in single center experience. (September 2015) Authors: Marconcini, R.; Ricci, S.; Antonuzzo, A.; Galli, L.; Vasile, E.; Farnesi, A.; Derosa, L.; Biasco, E.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2253 Interferon-based adjuvant chemoradiation in patients with resected pancreatic adenocarcinoma: Long-term outcomes. (September 2015) Authors: Montrone, S.; Coppola, M.; Cernusco, N.L.; Coraggio, G.; Menghini, V.; Delishaj, D.; Lombardo, E.; Pasqualetti, F.; Vasile, E.; Falcone, A.; Boggi, U.; Sainato, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2255 Safety and effectiveness of the combination of single chemotherapeutic agent (gemcitabine) with radiotherapy in radically resected pancreatic adenocarcinoma. (September 2015) Authors: Sainato, A.; Montrone, S.; Coppola, M.; Cernusco, N.L.; Ferrazza, P.; Cantarella, M.; Cocuzza, P.; Mazzotti, V.; Morganti, R.; Pasqualetti, F.; Vasile, E.; Falcone, A.; Boggi, U. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 2311 Evaluation of predictive factors of efficacy of Somatostatin Analogs (SSA) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): a single centre experience. (September 2015) Authors: Marconcini, R.; Ricci, S.; Galli, L.; Antonuzzo, A.; Vasile, E.; Pancrazi, F.; Farnesi, A.; Derosa, L.; Biasco, E.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2334 Nab Paclitaxel (Nab-P) and Gemcitabine (G) as first line chemotherapy (CT) in advanced pancreatic cancer (APDAC) patients (pts): An Italian "real life" study. (September 2015) Authors: Giordano, G.; Febbraro, A.; Vaccaro, V.; Zagonel, V.; De Giorgi, U.; Melisi, D.; Vasile, E.; Bianco, R.; Lo Re, G.; Valente, M.; Formica, V.; Montesarchio, V.; Maiorino, L.; Sanna, G.; Bittoni, A.; Ricci, V.; Santini, D.; Zaniboni, A.; Milella, M.; De Vita, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 2335 Analysis of activity, efficacy and safety of first line Nab Paclitaxel (Nab-P) and Gemcitabine (G) in advanced pancreatic cancer (APDAC) frail and elderly patients (pts). (September 2015) Authors: Giordano, G.; De Vita, F.; Melisi, D.; Vaccaro, V.; Zaniboni, A.; Zagonel, V.; Vasile, E.; Passardi, A.; Leo, L.; Ventriglia, J.; Marciano, R.; Russano, M.; Conca, R.; Andreozzi, F.; Lucchini, E.; Musettini, G.; Bertocchi, P.; Bergamo, F.; Milella, M.; Febbraro, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 2357 Prognostic factors in 709 advanced gastric cancer patients exposed to second-line therapy. (September 2015) Authors: Fontanella, C.; Fanotto, V.; Uccello, M.; Vasile, E.; Bozzarelli, S.; Filippi, R.; Santini, D.; Rosati, G.; Tomasello, G.; Silvestris, N.; Pietrantonio, F.; Bergamo, F.; Cinieri, S.; Melisi, D.; Antonuzzo, L.; Fornaro, L.; Cordio, S.; Pasquini, G.; Rimassa, L.; Aprile, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S454 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 2362 Second-line treatment after disease progression following first-line chemotherapy with modified FOLFIRINOX in advanced pancreatic cancer patients. (September 2015) Authors: Vivaldi, C.; Vasile, E.; Fornaro, L.; Caparello, C.; Musettini, G.; Pasquini, G.; Lencioni, M.; Ricci, S.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 2372 Is there a role for palliative gastrectomy in asymptomatic metastatic gastric cancer?. (September 2015) Authors: Musettini, G.; Caparello, C.; Pasquini, G.; Vivaldi, C.; Lencioni, M.; Petrini, I.; Fabrini, M.G.; Pallabazzer, G.; D'Imporzano, S.; Solito, B.; Santi, S.; Fornaro, L.; Vasile, E.; Falcone, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗